Serious infections on bDMARDs higher than expected: Australian study

Switching between biologics may be a factor

The number of serious infections in patients with rheumatoid arthritis taking biological disease-modifying anti-rheumatic drugs (bDMARDs) in a WA study is ’at the high end of the range generally reported’,  the authors say.